Banks v. ICI Americas, Inc., 264 Ga. 732 (1994)

Facts

  • Nine-year-old Marlo Strum died after ingesting Talon-G, a slow-acting anticoagulant rodenticide manufactured by ICI Americas, Inc. (ICI).

  • Marlo apparently believed the product was candy.

  • Talon-G had been kept at a local boys’ club in an unmarked container in a cabinet; the club was serviced by a pest-control company.

  • Marlo’s symptoms appeared only after a delay, and by then it was too late to administer an antidote effectively.

  • Marlo’s parents and the estate representative (the Bankses) sued ICI and others under negligence and strict-liability theories, alleging (1) defective design and (2) inadequate labeling/warnings.

  • As to design, the Bankses claimed Talon-G was unreasonably dangerous because it lacked a safety feature that could reduce the risk of child ingestion without impairing rodent-control performance.

  • The Bankses presented evidence, including testimony, that feasible alternative designs existed:

    • An emetic could cause rapid vomiting in humans but would not affect rats (rats cannot vomit).
    • An aversive agent could make the bait taste bad to children while remaining acceptable to rats.

  • The boys’ club and the pest-control company settled before verdict; ICI proceeded to verdict as the remaining defendant.

  • A jury awarded compensatory damages (subject to setoff for settlements) and $1 million in punitive damages against ICI.

  • The Georgia Court of Appeals reversed, reasoning that a manufacturer is not liable simply for failing to use the safest possible design and that Talon-G was reasonably suited for its intended purpose; it also held the failure-to-warn claim preempted by federal law.

  • The Georgia Supreme Court granted certiorari.

Issues

  1. What test governs Georgia design-defect claims under negligence and strict liability: whether the product is reasonably suited to its intended purpose, or a risk–utility balancing test considering safer feasible alternative designs?
  2. Does federal law (including FIFRA) preempt state-law failure-to-warn claims that challenge the adequacy of pesticide/rodenticide labeling?

Decision

  • The Supreme Court of Georgia adopted a risk–utility analysis as the governing method for deciding whether a product’s design is defective.
  • The court rejected the Court of Appeals’ approach that treated “reasonably suited to its intended purpose” as sufficient to defeat a design-defect claim.
  • The court explained that design-defect cases differ from manufacturing-defect cases and require weighing the product’s risks against its utility, including consideration of safer feasible alternative designs.
  • Because the Court of Appeals evaluated the design claim under the wrong standard, the Supreme Court reversed on the design-defect issue and ordered a new trial applying the risk–utility framework.
  • The court affirmed the Court of Appeals’ conclusion that the plaintiffs’ labeling-based failure-to-warn claim was preempted by federal law regulating pesticide labeling.
  • Disposition: affirmed in part, reversed in part, and remanded for further proceedings consistent with the risk–utility standard.

Legal Principles

  • Georgia design-defect claims are evaluated under a risk–utility balancing test, not a single inquiry into whether the product performed its intended function.

  • A product may be found defectively designed even if it is properly manufactured and works as intended; the question is whether the chosen design was reasonable in light of foreseeable risks and available safer design options.

  • Evidence of a safer feasible alternative design is relevant to the design-defect determination and may carry significant weight in the risk–utility balance.

  • Risk–utility analysis may consider factors such as:

    • the usefulness of the product,
    • the severity and likelihood of the danger,
    • the availability of a safer substitute or safer design,
    • the manufacturer’s ability to reduce danger without impairing usefulness or making the product too expensive,
    • the user’s ability to avoid danger through reasonable care,
    • the user’s anticipated awareness of the danger (including general knowledge and warnings), and
    • the feasibility of spreading the loss (for example, through pricing or insurance).

  • FIFRA preempts state-law failure-to-warn claims to the extent they would impose labeling requirements different from or in addition to federally approved pesticide labeling.

Conclusion

Banks held that Georgia design-defect liability turns on a risk–utility balancing test that permits the jury to weigh foreseeable risks against product benefits and safer feasible alternative designs; the court ordered a new trial on design defect while leaving the plaintiffs’ labeling-based failure-to-warn claim barred by federal preemption.